Скачать или смотреть RASopathies May Benefit From Cancer Research

RASopathies May Benefit From Cancer Research
Published Online: Saturday, Nov 08, 2014
2
inShare2

RASopathies are a group of genetic syndromes caused by germline mutations in genes associated with the Ras/mitogen-activated protein kinase (MAPK) pathway. This pathway is being studied by oncology researchers and RASopathies families are hopeful the cancer research will also lead to a better understanding of the various RASopathies (i.e., neurofibromatosis type 1, Noonan syndrome, Noonan syndrome with multiple lentigines, capillary malformation-arteriovenous malformation syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, and Legius syndrome).

In this exclusive interview with Rare Disease Report, Lisa Schoyer, President of the RASopathies Network USA talks about the RASopathies-Cancer connection and its likely importance at their upcoming 2015 scientific and patient conferences they have planned.

For more information about the organization, visit http://rasopathiesnet.org/